A detailed history of Berkshire Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Berkshire Asset Management LLC holds 405,714 shares of ABBV stock, worth $82.7 Million. This represents 3.47% of its overall portfolio holdings.

Number of Shares
405,714
Previous 388,310 4.48%
Holding current value
$82.7 Million
Previous $70.7 Million 1.59%
% of portfolio
3.47%
Previous 3.75%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $62.8 Million - $73.3 Million
405,714 New
405,714 $69.6 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $548,022 - $624,420
-3,429 Reduced 0.88%
388,310 $70.7 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $59,030 - $66,482
-429 Reduced 0.11%
391,739 $60.7 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $376,990 - $436,422
-2,822 Reduced 0.71%
392,168 $58.5 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $1.07 Million - $1.34 Million
8,101 Added 2.09%
394,990 $53.2 Million
Q1 2023

Jun 06, 2023

SELL
$144.61 - $166.54 $350,968 - $404,192
-2,427 Reduced 0.62%
386,889 $61.7 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $359,606 - $431,262
2,600 Added 0.67%
389,316 $63 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $685,947 - $786,736
-5,111 Reduced 1.3%
386,716 $51.9 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $948,614 - $1.21 Million
6,893 Added 1.79%
391,827 $60 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $491,229 - $609,477
3,722 Added 0.98%
384,934 $62.4 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $210,025 - $265,743
-1,955 Reduced 0.51%
381,212 $51.6 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $887,695 - $1.01 Million
8,343 Added 2.23%
383,167 $41.3 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $1.63 Million - $1.82 Million
15,501 Added 4.31%
374,824 $42.2 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $1.38 Million - $1.52 Million
-13,484 Reduced 3.62%
359,323 $38.9 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $2.63 Million - $3.55 Million
32,702 Added 9.62%
372,807 $39.9 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $2.22 Million - $2.61 Million
-25,853 Reduced 7.06%
340,105 $29.8 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $881,393 - $1.18 Million
12,013 Added 3.39%
365,958 $35.9 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $535,221 - $811,461
8,298 Added 2.4%
353,945 $27 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $579,420 - $724,978
-8,033 Reduced 2.27%
345,647 $30.6 Million
Q3 2019

Oct 07, 2019

SELL
$62.98 - $75.72 $1.08 Million - $1.3 Million
-17,191 Reduced 4.64%
353,680 $26.8 Million
Q2 2019

Jul 29, 2019

BUY
$65.7 - $83.98 $1.56 Million - $1.99 Million
23,732 Added 6.84%
370,871 $27 Million
Q1 2019

Apr 16, 2019

BUY
$77.14 - $90.79 $29,698 - $34,954
385 Added 0.11%
347,139 $28 Million
Q4 2018

Jan 24, 2019

SELL
$77.85 - $96.01 $22,732 - $28,034
-292 Reduced 0.08%
346,754 $32 Million
Q3 2018

Oct 12, 2018

BUY
$88.91 - $98.84 $1.4 Million - $1.56 Million
15,748 Added 4.75%
347,046 $32.8 Million
Q2 2018

Jul 17, 2018

BUY
$89.78 - $106.23 $284,153 - $336,217
3,165 Added 0.96%
331,298 $30.7 Million
Q1 2018

May 01, 2018

BUY
$92.01 - $123.21 $274,465 - $367,535
2,983 Added 0.92%
328,133 $31.1 Million
Q4 2017

Jan 17, 2018

BUY
$89.56 - $98.21 $2.34 Million - $2.57 Million
26,126 Added 8.74%
325,150 $31.4 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $20.9 Million - $26.7 Million
299,024
299,024 $26.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Berkshire Asset Management LLC Portfolio

Follow Berkshire Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.